MuSK antibody-positive, seronegative myasthenia gravis in Korea.

MuSK antibody-positive, seronegative myasthenia gravis in Korea.

Several reports from Western countries suggest differences in the clinical features of patients with muscle specific kinase (MuSK) antibody-positive and -negative seronegative myasthenia gravis (MG). We performed the first survey in Korea of MuSK antibodies, studying 23 patients with acetylcholine r...

Bibliográfalaš dieđut
Váldodahkkit:	Lee, J, Sung, J, Cho, J, Oh, D, Kim, H, Park, J, Lee, K, Choi, Y, Vincent, A
Materiálatiipa:	Journal article
Giella:	English
Almmustuhtton:	2006

Geahča maid

Detection and characterization of MuSK antibodies in seronegative myasthenia gravis.
Dahkki: McConville, J, et al.
Almmustuhtton: (2004)

Anti-MuSK antibodies in seronegative myasthenia gravis: a cause of denervation
Dahkki: Newsom-Davis, J, et al.
Almmustuhtton: (2001)

Myasthenia gravis with MuSK antibodies
Dahkki: Farrugia, M, et al.
Almmustuhtton: (2005)

Low frequency of MuSK antibody in generalized seronegative myasthenia gravis among Chinese.
Dahkki: Yeh, J, et al.
Almmustuhtton: (2004)

Infantile Onset Myasthenia Gravis with MuSK Antibodies
Dahkki: J Gordon Millichap
Almmustuhtton: (2006-08-01)

The prevalence of MuSK antibody positive myasthenia gravis worldwide
Dahkki: Vincent, A, et al.
Almmustuhtton: (2006)

The role of muscle-specific tyrosine kinase (MuSK) and mystery of MuSK myasthenia gravis.
Dahkki: Koneczny, I, et al.
Almmustuhtton: (2014)

The role of muscle-specific tyrosine kinase (MuSK) and mystery of MuSK myasthenia gravis
Dahkki: Koneczny, I, et al.
Almmustuhtton: (2014)

MuSK Antibody Positive Myasthenia Gravis Mimicking as Myositis
Dahkki: Nilesh Wagh, et al.
Almmustuhtton: (2024-09-01)

Potential mechanisms in MuSK-myasthenia gravis
Dahkki: Koneczny, I
Almmustuhtton: (2014)

MuSK-Myasthenia Gravis Unmasked by Hydroxychloroquine
Dahkki: Shalini Bhaskar, et al.
Almmustuhtton: (2022-01-01)

Clinical comparison of anti-MuSK- vs anti-AChR-positive and seronegative myasthenia gravis.
Dahkki: Deymeer, F, et al.
Almmustuhtton: (2007)

Anti-MuSK antibody positive myasthenia gravis with childhood onset
Dahkki: Diana Epure, et al.
Almmustuhtton: (2016-06-01)

Clinical Characteristics of MuSK Antibody-positive Myasthenia Gravis in Taiwan
Dahkki: Yung-Chuan Huang, et al.
Almmustuhtton: (2008-07-01)

MuSK-antibody-positive myasthenia gravis in a South Asian population.
Dahkki: Chang, T, et al.
Almmustuhtton: (2009)

Clinical aspects of MuSK antibody positive seronegative MG.
Dahkki: Sanders, D, et al.
Almmustuhtton: (2003)

Anti-MuSK antibodies in a case of ocular myasthenia gravis.
Dahkki: Bennett, D, et al.
Almmustuhtton: (2006)

Progress in rituximab for anti⁃MuSK antibody-related myasthenia gravis
Dahkki: Ting LI, et al.
Almmustuhtton: (2020-01-01)

Detection of musk antibodies in seronegative myasthenia gravis using human musk as antigen
Dahkki: McConville, J, et al.
Almmustuhtton: (2002)

Coexistence of anti-MuSK antibody-positive myasthenia gravis and rheumatoid arthritis
Dahkki: Amber Eker, et al.
Almmustuhtton: (2020-08-01)

Regional Features of MuSK Antibody-Positive Myasthenia Gravis in Northeast China
Dahkki: Zunwei Zhang, et al.
Almmustuhtton: (2020-10-01)

Patient-specific therapeutic benefit of MuSK agonist antibody ARGX-119 in MuSK myasthenia gravis passive transfer models
Dahkki: Jamie L. Lim, et al.
Almmustuhtton: (2025-02-01)

Acetylcholine receptors loss and postsynaptic damage in MuSK antibody-positive myasthenia gravis.
Dahkki: Shiraishi, H, et al.
Almmustuhtton: (2005)

Targeted treatment approaches and pathogenicity of antibody subclasses in MuSK-myasthenia gravis
Dahkki: Cao, M
Almmustuhtton: (2021)

MuSK-Associated Myasthenia Gravis: Clinical Features and Management
Dahkki: Carmelo Rodolico, et al.
Almmustuhtton: (2020-07-01)

Bortezomib in severe MuSK-antibody positive myasthenia gravis: first clinical experience
Dahkki: Christiane Schneider-Gold, et al.
Almmustuhtton: (2017-10-01)

Quantitative EMG studies to assess facial muscle atrophy in MuSK antibody positive myasthenia gravis
Dahkki: Farrugia, M, et al.
Almmustuhtton: (2007)

Strong association of MuSK antibody-positive myasthenia gravis and HLA-DR14-DQ5.
Dahkki: Niks, E, et al.
Almmustuhtton: (2006)

Guidelines for pre-clinical animal and cellular models of MuSK-myasthenia gravis.
Dahkki: Phillips, W, et al.
Almmustuhtton: (2015)

Auto-antibodies to the receptor tyrosine kinase MuSK in patients with myasthenia gravis without acetylcholine receptor antibodies.
Dahkki: Hoch, W, et al.
Almmustuhtton: (2001)

Compromised fidelity of B-cell tolerance checkpoints in AChR and MuSK myasthenia gravis
Dahkki: Lee, J, et al.
Almmustuhtton: (2016)

Immunotherapies in MuSK-positive Myasthenia Gravis; an IgG4 antibody-mediated disease
Dahkki: Aigli G. Vakrakou, et al.
Almmustuhtton: (2023-07-01)

Anti-MuSK antibody positive myasthenia gravis with Graves disease: one case report
Dahkki: Shan CAO, et al.
Almmustuhtton: (2019-02-01)

MRI and clinical studies of facial and bulbar muscle involvement in MuSK antibody-associated myasthenia gravis.
Dahkki: Farrugia, M, et al.
Almmustuhtton: (2006)

Efgartigimod treatment in patients with anti-MuSK-positive myasthenia gravis in exacerbation
Dahkki: Fangyi Shi, et al.
Almmustuhtton: (2024-11-01)

Myasthenia Crisis as First Presentation of MuSk Positive Myasthenia Gravis: A Case Report
Dahkki: Dipesh Chhetri, et al.
Almmustuhtton: (2025-02-01)

Differential Cytokine Changes in Patients with Myasthenia Gravis with Antibodies against AChR and MuSK.
Dahkki: Vuslat Yilmaz, et al.
Almmustuhtton: (2015-01-01)

Quantitative EMG of facial muscles in myasthenia patients with MuSK antibodies.
Dahkki: Farrugia, M, et al.
Almmustuhtton: (2007)

Anti-MuSK-Positive Myasthenia Gravis in a Patient with Parkinsonism and Cognitive Impairment
Dahkki: S. Lanfranconi, et al.
Almmustuhtton: (2011-01-01)

Fewer thymic changes in MuSK antibody-positive than in MuSK antibody-negative MG.
Dahkki: Leite, M, et al.
Almmustuhtton: (2005)